Related Experiment Videos
Technology in interventional cardiology: percutaneous transluminal coronary angioplasty
1Department of Invasive Cardiology, Royal Brompton and National Heart Hospital, London.
Insights
Percutaneous transluminal coronary angioplasty (PTCA) offers myocardial revascularization but faces challenges like diffuse disease and restenosis. Ongoing advancements aim to improve initial success, reduce emergency bypass surgery, and lower restenosis rates.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for myocardial revascularization.
- Despite its widespread use, PTCA has limitations including unsuitability for diffuse coronary artery disease and chronic occlusions.
Purpose of the Study:
- To review the limitations of Percutaneous transluminal coronary angioplasty (PTCA).
- To discuss complications such as acute vessel occlusion and restenosis.
- To highlight advancements aimed at improving PTCA outcomes.
Main Methods:
- Review of existing literature on Percutaneous transluminal coronary angioplasty (PTCA) outcomes and complications.
- Analysis of factors contributing to procedural failure and restenosis.
- Examination of technological and procedural advancements in PTCA.
Main Results:
- PTCA is effective for many patients but unsuitable for diffuse coronary artery disease and chronic occlusions.
- Acute vessel occlusion occurs in ~5% of procedures, often necessitating emergency coronary artery bypass surgery (CABG).
- Restenosis, or re-narrowing of the treated artery, affects approximately 30% of patients within 3-6 months post-PTCA.
Conclusions:
- Significant challenges remain in Percutaneous transluminal coronary angioplasty (PTCA) efficacy and safety.
- Advancements since the 1970s focus on enhancing initial success rates.
- Key goals include reducing the need for emergency CABG and mitigating restenosis incidence.
Abstract:
Percutaneous transluminal coronary angioplasty (PTCA) is now capable of providing myocardial revascularization in a majority of patients, but significant problems with the technique remain. It is unsuitable for dealing with diffuse coronary artery disease, chronically occluded vessels may be impossible to disobliterate, and disease of the distal coronary vessel may be difficult to reach with a balloon. Approximately 5 percent of all procedures may be complicated by acute occlusion of the target vessel, usually by dissection of the arterial intima, often resulting in a need for emergency coronary artery bypass surgery (CABG). Furthermore, there is recurrence of the dilated lesion--'restenosis'--in approximately 30 percent of cases in the first 3 to 6 months after PTCA. Advances in this technique, since its introduction in the mid 1970s, have been directed at making initial success more likely, obviating the need for emergency CABG, and reducing the incidence of restenosis.